Summary of Key Information:
Reporting Period: Quarter ended 30 June 2026
Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015
Audit Opinion:
Clean opinion - Limited review report from M/s. B.K. Chavda & Co. stated nothing came to their attention causing belief that the financial results contain material misstatement.
Key Financial Highlights [Amount in Lakhs]:
Standalone Results:
Revenue from Operations: ₹2531.12 lakh (Q1 FY27) vs ₹4591.04 lakh (Q1 FY26) - 44.9% decrease YoY
Total Income: ₹2538.29 lakh (Q1 FY27) vs ₹4628.40 lakh (Q1 FY26) - 45.2% decrease YoY
Net Profit: ₹(1141.68) lakh loss (Q1 FY27) vs ₹10.77 lakh profit (Q1 FY26) - Significant deterioration
EPS: ₹(3.56) (Q1 FY27) vs ₹0.04 (Q1 FY26)
Paid-up equity share capital: ₹6034.60 lakh (Face Value ₹10 each)
Consolidated Results:
Revenue from Operations: ₹2531.12 lakh (Q1 FY27)
Total Income: ₹2578.31 lakh (Q1 FY27)
Net Profit: ₹(1143.66) lakh loss (Q1 FY27)
EPS: ₹(3.57) (Q1 FY27)
Paid-up equity share capital: ₹6035.60 lakh (Face Value ₹10 each)
Expense Breakdown (Standalone):
Cost of Materials consumed: ₹1848.68 lakh
Purchase of stock-in-trade: ₹1549.53 lakh
Changes in inventories: ₹120.87 lakh
Employee benefits expense: ₹40.68 lakh
Finance Costs: ₹3.68 lakh
Depreciation and amortisation: ₹46.11 lakh
Other Expenses: ₹66.78 lakh
Total Expenses: ₹3676.33 lakh
Segment-wise Performance:
The operations fall under chemical business which is the only reportable business segment as per Ind AS 108.
Corporate Actions:
No dividend declarations, share splits, bonus issues, or buybacks announced.
Director Appointments:
- Mr. Alok Jain (DIN: 01892711) appointed as Additional Non-Executive Independent Director
- Mr. Anubhav Agarwal appointed as Additional Director on 05.06.2026
- Mr. Gaurav Kumar Tripathi appointed as Whole-time Director on 05.06.2026
- Mr. Piyush Bichhoriya appointed as Additional Director on 05.06.2026
- Mr. Sanmitra Trivedi appointed as Additional Director on 08.05.2026
- Ms. Jalpa Anand Lavingia appointed as Additional Director on 08.05.2026
Officer Appointments:
- Mr. Amit Kalra appointed as Chief Financial Officer on 05.06.2026
- Ms. Nidhi Dixit appointed as Company Secretary on 05.06.2026
Auditor Appointments:
- M/s Dileep Verma & Associates, Cost Accountants appointed as Cost Auditor
- Mr. Vaibhav Kumar Valiyan appointed as Internal Auditor
Other Significant Information:
Change in Control and Acquisition:
During the quarter ended 30 June 2026, pursuant to Share Swap and Share Purchase Agreement dated 20 March 2026, BNG Investment LLC and Mr. Anubhav Agarwal became new promoters/acquirers of the Company.
The Company acquired 100% equity share capital of Agastya Green Energy Limited (94,99,994 equity shares + 6 nominee shares) as consideration other than cash, issuing 1,52,87,356 equity shares of the Company to BNG Investment LLC. Transaction completed on 10 June 2026, making AGEL a wholly owned subsidiary.
Loan to Subsidiary:
Company granted loan aggregating to ₹26.75 crore to AGEL carrying interest at 9% per annum, approved by Board.
Strategic Expansion:
Company initiated strategic entry into renewable energy sector including renewable energy products manufacturing, Independent Power Producer (IPP) and Engineering, Procurement and Construction (EPC) activities under AGASTYA platform.
Members approved alteration of Company's object clause at Extraordinary General Meeting held on 7 August 2026 to facilitate expansion into renewable energy and other emerging business segments.
Consolidation Details:
Consolidated financial results include Sanginita Chemicals Limited and its five subsidiaries (one direct subsidiary and four step-down subsidiaries) all engaged in generation of renewable energy and allied activities.
AGEL and its subsidiaries consolidated from 10 June 2026. Comparative figures for Q1 FY26 and FY26 represent standalone financial results of Parent Company only.